Biocompatible Delivery System for Metformin: Characterization, Radiolabeling and In Vitro Studies


Aydin B., Ucar E., Tekin V., İÇHEDEF Ç. , TEKSÖZ S.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, vol.20, no.13, pp.1626-1634, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 13
  • Publication Date: 2020
  • Doi Number: 10.2174/1871520620666200423081235
  • Title of Journal : ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
  • Page Numbers: pp.1626-1634

Abstract

Background: In recent years, the uses of nanotechnology in medicine have an increasing potential as an effective nanocarrier system. These systems are improved with the purpose of maximizing therapeutic activity and minimizing undesirable side-effects. Moreover, radiolabeled nanoparticles can be used as agents for diagnosis and therapeutic purposes in clinical applications. They have three main components: the core, the targeting biomolecule, and the radionuclide.